GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hansoh Pharmaceutical Group Co Ltd (STU:3KY) » Definitions » Sale Of Investment

Hansoh Pharmaceutical Group Co (STU:3KY) Sale Of Investment : €293 Mil (TTM As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Hansoh Pharmaceutical Group Co Sale Of Investment?

Hansoh Pharmaceutical Group Co's sale of investment for the six months ended in Dec. 2023 was €-179 Mil. It means Hansoh Pharmaceutical Group Co gained €-179 Mil from selling investments. Hansoh Pharmaceutical Group Co's sale of investment for the trailing twelve months (TTM) ended in Dec. 2023 was €293 Mil.

Compared with last quarter (€471 Mil in Jun. 2023 ), Hansoh Pharmaceutical Group Co gained less money from selling investments in Dec. 2023 (€-179 Mil).


Hansoh Pharmaceutical Group Co Sale Of Investment Historical Data

The historical data trend for Hansoh Pharmaceutical Group Co's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hansoh Pharmaceutical Group Co Sale Of Investment Chart

Hansoh Pharmaceutical Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial 7.90 532.26 1,028.56 81.53 290.96

Hansoh Pharmaceutical Group Co Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 132.53 61.73 22.37 471.25 -178.61

Hansoh Pharmaceutical Group Co Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €293 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hansoh Pharmaceutical Group Co Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Hansoh Pharmaceutical Group Co's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Hansoh Pharmaceutical Group Co (STU:3KY) Business Description

Traded in Other Exchanges
Address
287 Xiangke Road, Pudong New District, Shanghai, CHN, 201210
Hansoh Pharmaceutical Group Co Ltd is a research and development-driven pharmaceutical company in China. The company holds a broad, diversified drug portfolio in CNS diseases, oncology, anti-infectives, and diabetes. Further, it also focuses on metabolic diseases and anti-tumor. The majority of revenue is generated from the sale of pharmaceutical products in Mainland China.

Hansoh Pharmaceutical Group Co (STU:3KY) Headlines

No Headlines